Skip to content
PICO Portalanswers from OpenAlex

Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis

PaperCitations, authors & open-access status

Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis have?

PICO Portalcitation count

Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis has 691 citations in the OpenAlex counts PICO Portal stores.

When was Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis published?

PICO Portalyear

Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis has 2018 year in the PICO Portal index.

What is the open-access status of Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis?

PICO Portaloa status

Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis has hybrid oa status in the PICO Portal index.

What is the DOI of Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis?

PICO Portaldoi

The DOI for Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis is on the source record.

What is the PMID of Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis?

PICO Portalpmid

The PMID for Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis is on the source record.

What is the OpenAlex record for Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis?

PICO Portalopenalex

The OpenAlex for Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial